The journal PLOS Pathogens abruptly retracts the seminal paper linking XMRV to disease.
The Scientist
Most Recent
A seventh patient succumbs to a deadly, drug-resistant superbug terrorizing the National Institutes of Health Clinical Center.
Reinvestigating a natural antibiotic compound reveals its potential as a tuberculosis drug.
Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.
Researchers identified the 3-step process leaf-cutter ants use to grow helpful bacteria on their bodies.
Friendly sinus bacteria may keep sinusitis-causing strains in check.
A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.
With a cardboard box, a light source, and some filters, roadside clinics can accurately test for tuberculosis.
Contributors
September 1, 2012
Meet some of the people featured in the September 2012 issue of The Scientist.
Mimicking a host-cell histone protein offers flu a sneaky tactic to suppress immune response.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
